Wells Fargo’s Moleculin Biotech MBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-19
| Closed | -$112 | – | 6775 |
|
|
2024
Q1 | $112 | Buy |
19
+4
| +27% | +$24 | ﹤0.01% | 6233 |
|
|
2023
Q4 | $197 | Sell |
15
-33
| -69% | -$433 | ﹤0.01% | 6171 |
|
|
2023
Q3 | $307 | Buy |
48
+34
| +243% | +$217 | ﹤0.01% | 6096 |
|
|
2023
Q2 | $124 | Buy |
14
+1
| +8% | +$9 | ﹤0.01% | 6517 |
|
|
2023
Q1 | $190 | Sell |
13
-22
| -63% | -$322 | ﹤0.01% | 6466 |
|
|
2022
Q4 | $552 | Buy |
35
+22
| +169% | +$347 | ﹤0.01% | 6033 |
|
|
2022
Q3 | $0 | Hold |
13
| – | – | ﹤0.01% | 6751 |
|
|
2022
Q2 | $0 | Sell |
13
-265
| -95% | – | ﹤0.01% | 6905 |
|
|
2022
Q1 | $7K | Hold |
278
| – | – | ﹤0.01% | 6032 |
|
|
2021
Q4 | $7K | Buy |
278
+266
| +2,217% | +$6.7K | ﹤0.01% | 6091 |
|
|
2021
Q3 | $1K | Buy |
12
+1
| +9% | +$83 | ﹤0.01% | 6404 |
|
|
2021
Q2 | $1K | Hold |
11
| – | – | ﹤0.01% | 6348 |
|
|
2021
Q1 | $1K | Buy |
11
+7
| +175% | +$636 | ﹤0.01% | 6366 |
|
|
2020
Q4 | $0 | Sell |
4
-913
| -100% | – | ﹤0.01% | 6420 |
|
|
2020
Q3 | $67K | Buy |
917
+50
| +6% | +$3.65K | ﹤0.01% | 5182 |
|
|
2020
Q2 | $76K | Buy |
867
+857
| +8,570% | +$75.1K | ﹤0.01% | 5119 |
|
|
2020
Q1 | $0 | Sell |
10
-25
| -71% | – | ﹤0.01% | 6150 |
|
|
2019
Q4 | $3K | Hold |
35
| – | – | ﹤0.01% | 5723 |
|
|
2019
Q3 | $3K | Buy |
35
+7
| +25% | +$600 | ﹤0.01% | 5703 |
|
|
2019
Q2 | $3K | Buy |
+28
| New | +$3K | ﹤0.01% | 5680 |
|
|
2018
Q2 | – | Sell |
-56
| Closed | -$9K | – | 5978 |
|
|
2018
Q1 | $9K | Buy |
+56
| New | +$9K | ﹤0.01% | 5575 |
|